Where should the drug industry go to find new ideas? In the first of two features, Alison Abbott asks if the future lies in systems biology -- a field that attempts to piece together 'everything'. In the second, David Cyranoski looks at drug companies' attraction to China.
This is a preview of subscription content, log in via an institution to check access.
References
Zhang, H., Li, X. J., Martin, D. B. & Aebersold, R. Nature Biotechnol. 21, 660–666 (2003).
Hendriks, B. S. et al. IEE Proc. Syst. Biol. 153, 22–33 (2006).
Chen, Y. et al. Nature 452, 429–435 (2008).
Emilsson, V. et al. Nature 452, 423–428 (2008).
Additional information
Alison Abbott is Nature's senior European correspondent.
Related links
Related links
Related external links
Rights and permissions
About this article
Cite this article
Abbott, A. Pharmaceutical futures: A fiendish puzzle. Nature 455, 1164–1167 (2008). https://doi.org/10.1038/4551164a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4551164a
- Springer Nature Limited